Michael H. Davidson, CEO: NewAmsterdam Pharma NAMS Planned sale · Filed 25/03/26

Trade details

Type: Planned sale notice
Stock: NewAmsterdam Pharma NAMS
Person: Michael H. DavidsonCEO
Planned sale date: 25/03/26
Filed: 25/03/26

$287K to be sold

NewAmsterdam Pharma trades, last 26 weeks

What else happened in NewAmsterdam Pharma around then

Filed or reported within 30 days of the trade day · 25/02/24~25/04/25

Michael H. Davidson's recent trades

Michael H. DavidsonCEO
SellNewAmsterdam Pharma
Sell
NewAmsterdam Pharma
NAMS
$14.8M
443,707 sh
$14.8M
Filed 03/02
Traded 03/02
Michael H. DavidsonAffiliate
Planned saleNewAmsterdam Pharma
Planned sale
NewAmsterdam Pharma
NAMS
$15.7M
443,707 sh
$15.7M
Filed 03/02
Traded 03/02
Michael H. DavidsonCEO
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$5.6M
165,408 sh
$5.6M
Filed 02/26
Traded 02/26
Michael H. DavidsonCEO
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$2.2M
61,547 sh
$2.2M
Filed 02/26
Traded 02/24
Michael H. DavidsonCEO
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$1.6M
46,517 sh
$1.6M
Filed 02/26
Traded 02/25

Michael H. Davidson, CEO — plans to sell 12,258 sh of NewAmsterdam Pharma NAMS · $287K · around 03/26 | Whalegun